SCHEMBL8740454

SCHEMBL8740454

CC(SO)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95981 0.76 TP53 (0.47)
SCHEMBL78432 0.76 TP53 (0.47)
SCHEMBL9715475 0.75
SCHEMBL990356 0.73
SCHEMBL20593290 0.73 TP53 (0.44)
Ammonia Solution, Strong SCHEMBL8958635 0.73 TP53 (0.44)
SCHEMBL8688833 0.73
SCHEMBL11317937 0.73 TP53 (0.44)
SCHEMBL8691719 0.73
Hydrogen Sulfide SCHEMBL9001004 0.73 TP53 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0701446-A4 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1997-04-23 EP claimed
EP-0701446-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1996-03-20 EP claimed
WO-1994027627-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-12-08 WO claimed
EP-0701446-A4 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1997-04-23 EP disclosed
EP-0701446-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1996-03-20 EP disclosed
US-5459236-A Hypertensive agents FERRING AB (SE) 1995-10-17 US disclosed
WO-1994027627-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-12-08 WO disclosed
EP-0380554-B1 VASOACTIVE PEPTIDES Ferring AB (SE) 1993-07-07 EP disclosed
EP-0380554-A1 VASOACTIVE PEPTIDES. FERRING AB (SE) 1990-08-08 EP disclosed
WO-1989003393-A1 VASOACTIVE PEPTIDES FERRING AB (SE) 1989-04-20 WO disclosed